Eagle’s Eye View: How Can We Estimate CV Risk for Patients With Type 2 Diabetes?
Release Date:
In this week’s View, Dr. Eagle looks at SCORE2-Diabetes, a 10-year CV risk estimator for patients with type 2 diabetes. He then discusses the value of sex-specific stress perfusion cardiac MRI in suspected ischemic heart disease. Finally, Dr. Eagle explores a paper on managing patients with moderate aortic valve stenosis. Subscribe to Eagle’s Eye View
Eagle’s Eye View: How Can We Estimate CV Risk for Patients With Type 2 Diabetes?